Cabozantinib drug introduction

Cabozantinib (Cabozantinib) is a targeted therapy drug that belongs to the category of multi-target tyrosine kinase inhibitors. It is designed to treat several types of cancer, including advanced renal cell carcinoma, thyroid cancer, and hepatocellular carcinoma. Cabozantinib is an oral medication that is usually available in capsule form.

As a targeted therapy drug, cabozantinib’s mechanism of action is mainly by inhibiting multiple key signaling pathways, thereby inhibiting the growth, spread and angiogenesis of cancer cells. Cabozantinib mainly acts on multiple receptor tyrosine kinases (RTKs), including MET (hepatocyte growth factor receptor), VEGFR (vascular endothelial growth factor receptor) , RET (rearranged oncogene family receptor kinase), KIT (cytoplasmic tyrosine kinase) and AXL (axon-associated protein kinase), etc. By inhibiting the activity of these receptor tyrosine kinases, cabozantinib can effectively block the growth signaling of tumor cells, thereby inhibiting the growth and metastasis of tumor cells.

In addition, cabozantinib can also inhibit the vascular endothelial growth factor (VEGF) signaling pathway, thereby inhibiting the formation of new blood vessels in tumors, reducing the blood supply to tumors, and thereby inhibiting tumor growth and metastasis.

Cabozantinib is often used as a single agent or in combination with other treatments, such as immunotherapy or chemotherapy, to treat patients with advanced cancer. Its dosage and treatment regimen may vary depending on the patient's condition and doctor's recommendations.

Although cabozantinib has shown good efficacy in cancer treatment, it may also cause a series of adverse reactions, including hypertension, diarrhea, hand-foot syndrome, fatigue, dry mouth, etc. Therefore, while using cabozantinib, patients need to pay close attention to changes in their physical condition and promptly inform their doctors of any symptoms of discomfort so that the treatment plan can be adjusted in a timely manner.

In general, cabozantinib, as a targeted therapy, plays an important role in the treatment of patients with advanced cancer. However, patients need to follow their doctor's instructions when using cabozantinib and pay attention to possible adverse reactions to ensure the best therapeutic effect.